Trial Profile

An Open-label, Single-arm Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents Aged ≥12 to ≤17 Years At the Time of Study Inclusion with Active Moderate to Severe Hidradenitis Suppurativa

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 30 Jun 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

22 Jun 2026 According to a MoonLake Immunotherapeutic media release, the company will hold an Investor Day for investors and analysts on June 22, 2026 to present data from this trial
22 Jun 2026 Results published in the MoonLake Immunotherapeutic Media Release
06 May 2026 Planned End Date changed from 27 Mar 2026 to 28 Sep 2026.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com